Menu

Department
  • Biochemistry
  • Back

    Dr Jules Griffin

    University Position
    Royal Society University Research Fellow

    Interests

    We have been using a range of analytical techniques, and in particular NMR spectroscopy and mass spectrometry, to follow metabolism in the brain in a range of disease processes. This ranges from flux measurements to understand the cycling of metabolites between neuronal and glial cells and how this process is influenced by drug intervention to the development of pattern recognition tools to identify metabolic profiles associated with a given disease process. The majority of work has centered on mouse models of disease and in particular we have examined models of Alzheimer?s disease, Parkinson's disease and the Neuronal Ceroid Lipofuscinoses. This has also been augmented by cell culture and human post mortem tissue work. These approaches are high throughput and provide a rapid mechanism to screen for metabolic perturbations within brain tissue. We also have an interest in developing new bioinformatic tools for examining multivariate data.

    Key Publications

    Publications

    An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors.

    DOI: http://doi.org/10.1021/acs.jproteome.8b00786
    Journal: J Proteome Res
    E-pub date: 7 Jun 2019
    Authors: EL Harshfield, A Koulman, D Ziemek, L Marney, EB Fauman, DS Paul, D Stacey, A Rasheed, J-J Lee, N Shah, S Jabeen, A Imran, S Abbas, Z Hina, N Qamar, NH Mallick, Z Yaqoob, T Saghir, SNH Rizvi, A Memon, SZ Rasheed, F-U-R Memon, IH Qureshi, M Ishaq, P Frossard, J Danesh, D Saleheen, AS Butterworth, AM Wood, JL Griffin

    An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease.

    DOI: http://doi.org/10.1007/s00415-017-8647-0
    Journal: J Neurol
    E-pub date: 1 Dec 2017
    Authors: BR Underwood, ZW Green-Thompson, PJ Pugh, SE Lazic, SL Mason, J Griffin, PS Jones, JB Rowe, DC Rubinsztein, RA Barker

    Genomics of lipid metabolism: Identifying novel causal pathways and new therapeutic targets for reducing risk of coronary heart disease

    DOI: http://doi.org/10.1002/gepi.22001
    Journal: Genetic Epidemiology
    E-pub date: 28 Sep 2016
    Authors: EL Harshfield, D Stacey, DS Paul, A Koulman, AM Wood, A Butterworth, EB Fauman, JL Griffin, J Danesh, D Saleheen